Perpetual Investment Management’s Gilead Sciences GILD Stock Holding History

Perpetual Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.13M	Sell	13,132 -4,500	-26%	-$356K	0.13%	98
2022 Q3	$1.09M	Buy	17,632 +60	+0.3%	+$3.78K	0.16%	97
2022 Q2	$1.09M	Buy	17,572 +1,400	+9%	+$86.7K	0.16%	114
2022 Q1	$961K	Hold	16,172	–	–	0.12%	130
2021 Q4	$1.18M	Buy	16,172 +256	+2%	+$17.6K	0.13%	122
2021 Q3	$1.11M	Hold	15,916	–	–	0.14%	125
2021 Q2	$1.1M	Hold	15,916	–	–	0.16%	122
2021 Q1	$1.03M	Hold	15,916	–	–	0.17%	90
2020 Q4	$902K	Buy	+15,916	New	+$960K	0.13%	113

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perpetual Investment Management's GILD Position: Q4 2022 in Review

Perpetual Investment Management reduced its Gilead Sciences (GILD) stake by 26% in Q4 2022, selling an estimated $356K and leaving 13,132 shares worth $1.13M. The position accounts for 0.13% of the portfolio, ranked #98.

Perpetual Investment Management first reported a position in GILD in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.18M in Q4 2021. 1,766 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Perpetual Investment Management held 13,132 shares of Gilead Sciences worth $1.13M as of Q4 2022.
Perpetual Investment Management sold 4,500 Gilead Sciences shares in Q4 2022, an estimated $356K.
Gilead Sciences made up 0.13% of Perpetual Investment Management's portfolio in Q4 2022, its #98 holding.
Perpetual Investment Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 9 quarters since.
Perpetual Investment Management's Gilead Sciences position peaked at $1.18M in Q4 2021.
1,766 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.